Benzinga | Aug 6, 2020 07:10AM EDT

Abiomed Q1 Adj. EPS $0.59 Beats $0.29 Estimate, Impella Sales $155.40M Beat $151.11M Estimate

Abiomed (NASDAQ:ABMD) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.29 by 103.45 percent. This is a 41 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $155.40 million which beat the analyst consensus estimate of $151.11 million by 2.84 percent. This is a 25.17 percent decrease over sales of $207.67 million the same period last year.